Biotechnology, Biomedical and Bioinformatics News

Fast-acting impotency drug outpaces rivals: study (AFP)

AFP — Biotech firm Vivus unveiled a would-be player Mon­day in the 3.7-billion-dollar erec­tile dys­func­tion mar­ket: avanafil, effec­tive in just 15 min­utes, far faster than block­buster rivals Via­gra and Cialis.

Con­tin­ued here:
Fast-acting impo­tency drug out­paces rivals: study
(AFP)